Novosti
Khirurgii
This journal is
indexed in Scopus









Year 2022 Vol. 30 No 1

ANESTHESIOLOGY-REANIMATOLOGY

DOI: https://dx.doi.org/10.18484/2305-0047.2022.1.61   |  

V.Y. ZIAMKO 1, V. K. OKULICH 1, A.M. DZYADZKO 2

STRUCTURE OF MICROFLORA AND ANTIBIOTIC RESISTANCE TRENDS IN INTENSIVE CARE UNIT OF A MULTIDISCIPLINE INSTITUTION

Vitebsk State Medical University , Vitebsk,
Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology 2, Minsk,
Republic of Belarus

Objective. To study dynamics of structure and antibiotic resistance of microflora in the intensive care unit depending on the amount of used antibiotics.
Methods. 41375 isolates were studied in the intensive care unit of a multidisciplinary hospital from 2015 to early 2021. Bacteriological examination of clinical samples on basis of Republican Scientific and Practical Center Infection in Surgery has been performed. The primary treatment of results with the analysis of sensitivity of microorganisms to antibiotics was carried out by means of International Computer Program (WHONET). Antibiotic sensitivity was determined by disk-diffusion method, suspended in Mueller-Hinton broth and semi-automatic analyzer ATB Expression (BioMerieux, France). The analysis of consumption of antibacterial drugs in the intensive care unit was carried out according to data of pharmacy which operates at the medical institution where the research itself was carried out.
Results. From 2015 to 2017 the analysis of microflora composition permitted to establish the prevalence of P. aeruginosa (22,74%), Acinetobacter spp. (22,25%) and K. pneumoniae (16,11%) which occurred 1,6 folds more often than other microorganisms while in general structure of multidisciplinary hospital S. aureus was most common (20,96% and 20,05%). Since 2018 carbapenem-resistant K. pneumonia has dominated (23,01%). Tigecycline and colistat were not effective against 4,3% and 5,7% of K. pneumoniae isolates in 2019, 10,2% and 13,7% of isolates in 2020, 37,3% and 39,6% from January to May 2021 which was associated with a growth of tigecycline and colistat consumption.
Conclusion. Since 2018 prevalence of carbapenem-resistant K. pneumoniae has been observed in microflora of the intensive care unit which is associated with a growth of consumption of antibacterial drugs which caused appearance of K. pneumoniae isolates resistant to colistin and tigecycline.

Keywords: microbiota, lung microbiome, infection, antibiotics. intensive care unit, antibiotic resistance
p. 61-73 of the original issue
References
  1. Walsh F. The multiple roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013 Aug 27;4:255. doi: 10.3389/fmicb.2013.00255. eCollection 2013.
  2. Zou Y, Lian J, Di Y, You H, Yao H, Liu J, Dong Y. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units. Int J Clin Pharm. 2018 Feb;40(1):175-82. doi: 10.1007/s11096-017-0524-5
  3. Walkty A, Lagace-Wiens P, Adam H, Baxter M, Karlowsky J, Mulvey MR, McCracken M, Zhanel GG. Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: results of the Canadian Ward surveillance study (CANWARD), 2008-2015. Diagn Microbiol Infect Dis. 2017 Jan;87(1):60-63. doi: 10.1016/j.diagmicrobio.2016.10.003
  4. Kidd TJ, Mills G, Sá-Pessoa J, Dumigan A, Frank CG, Insua JL, Ingram R, Hobley L, Bengoechea JA. A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Mol Med. 2017 Apr;9(4):430-47. doi: 10.15252/emmm.201607336
  5. Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, Pilcher DV; Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA. 2017 Jan 17;317(3):290-300. doi: 10.1001/jama.2016.20328
  6. VOZ publikuet spisok bakterij, dlja borby s kotorymi srochno trebuetsja sozdanie novyh antibiotikov [Jelektronnyj resurs]. Zheneva: VOZ [data obrashhenija: 2021 Apr 10]. Available from: https://www.who.int/ru/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (In Russ.)
  7. Pentima MC, Chan S, Briody C, Power M, Hossain J. Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children. Antimicrob Resist Infect Control. 2014;3:29. doi: 10.1186/2047-2994-3-29
  8. Karpov IA, Berdyklychev BA, Zareckij SV, Sivec NF, Dzjadzko AM, Gavrilenko LN, Davidovskaja LI, Rozhko JuV, Tonko OV, Varivoda EB, Zaharenko, AG, Dashkevich AM, Titov LP. Strategija borby s antibiotikorezistentnostju mikroorganizmov. Zdravoohranenie [Internet]. 2017 Okt;(10). http://www.zdrav.by/kruglyj-stol/strategiya-borby-s-antibiotikorezistentnostyu-mikroorganizmov (In Russ.)
  9. Titov LP, Gorbunov VA, Kharkhal FN, Davydov AV, Levshina NN. Trend in invasive bacterial diseases pathogenesis resistance to antibiotiotics:microbiological monitoring 2012-2017. Zdravoohranenie. 2019;(7):5-16. https://www.zdrav.by/pdf/2019/Zdrav7_19.pdf (In Russ.)
  10. Lagun LV. Zhavoronok SV. Genodetection of extended-spectrum P-lactamases of various groups in etiologic agents of pyelonephritises. Lab Diagnostika. 2012;(2):74-85 (In Russ.)
  11. Ugrakli S, Okumuş EÜ, Doğan MJ. Identification of bacterial pathogens in blood specimens andantibiotic resistance profiles of Acinetobacter species in a University hospital. J Clinical Microbiol Biochem Technol. 2017;2(1):4-8. doi: 10.17352/jcmbt.000017
  12. Gorbich UL, Karpov IA, Krechikova OI. Infections, induced by Acinetobacter baumannii: risk factors, diagnostics, treatment, prevention approaches. Med Novosti. 2011;(5):31-39. http://www.mednovosti.by/journal.aspx?article=4987 (In Russ.)
  13. Peterson LR. Bad bugs, no drugs: no ESCAPE revisited. Clin Infect Dis. 2009 Sep 15;49(6):992-93. doi: 10.1086/605539
  14. Meletis G, Oustas E, Botziori C, Kakasi E, Koteli A. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol. 2015 Jul;38(3):417-21.
  15. van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KS. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2015 Aug;36(8):942-8. doi: 10.1017/ice.2015.118
  16. Sharma SK, Hadda V, Mathur P, Gulati V, Sahney C. Profile of micro-organisms in intensive care unit of a level-1 trauma centre: a retrospective study. Indian J Crit Care Med. 2013 Mar;17(2):87-91. doi: 10.4103/0972-5229.114827
Address for correspondence:
210009, Republic of Belarus,
Vitebsk, 27, Frunze Ave.,
Vitebsk State Medical University,
Department of Anesthesiology and Resuscitation,
tel. mobile: +375291460799,
e-mail: viktoryiazia@gmail.com,
Ziamko Viktoryia Y.
Information about the authors:
Ziamko Viktoryia Y., PhD, Associate Professor of the Department of Anesthesiology and Resuscitation, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0002-6753-2074
Okulich Vitaly K., PhD, Associate Professor of the Department of Clinical Microbiology, Vitebsk State Medical University, Vitebsk, Republic of Belarus.
https://orcid.org/0000-0002-8226-6405
Dzyadzko Alexander M., MD, Head of the Department of Anesthesiology and Resuscitation, Minsk Scientific and Practical Center of Surgery, Transplantation and Hematology, Minsk, Republic of Belarus.
https://orcid.org/0000-0003-1965-1850
Contacts | ©Vitebsk State Medical University, 2007